CLS: Clinical Trial Agreement With Skåne University Hospital - Redeye

Redeye endorses CLS entering into a clinical trial agreement with Skåne University Hospital to evaluate MR-guided Laser Interstitial Thermal Therapy (LITT) for glioblastoma ablation. With this agreement in place, CLS is progressing within neurosurgery which we see as a very interesting field for the company over the coming years. We continue to argue that the share is attractive at current share price levels.

Länk till analysen i sin helhet: https://www.redeye.se/research/832374/cls-clinical-trial-agreement-with-skane-university-hospital?utm_source=finwire&utm_medium=RSS